Antimicrobial properties and biomedical potential of zinc oxide nanoparticles in pediatric diarrhea: A narrative review

• This manuscript presents a narrative review of the rule of ZnO-NPs in diarrhea treatment. • We identify critical gaps in the existing literature, particularly in this topic, that require further exploration. • A novel framework is proposed to enhance understanding and guide future research directions in the field. • Our findings emphasize the importance of using ZnO-NPs in diarrhea treatments. Zinc oxide nanoparticles (ZnO NPs) have been extensively investigated for their antimicrobial activity and potential relevance to pediatric diarrhea, owing to their size-dependent reactivity and ability to generate reactive oxygen species. This review critically examines recent experimental and preclinical studies reporting the antimicrobial effects of ZnO NPs, with particle sizes typically ranging from 10 to 80 nm and effective concentrations between 5 and 200 µg/mL. In vitro studies commonly report bacterial growth inhibition rates of 60–95% against enteric pathogens such as Escherichia coli and Salmonella spp., with smaller particles and surface-modified ZnO NPs showing enhanced activity compared to bulk ZnO and soluble zinc salts. Comparative analysis indicates that ZnO NPs often achieve similar or improved antimicrobial efficacy at lower zinc doses, while also exhibiting variable cytotoxicity depending on particle size, surface chemistry, and exposure duration. However, reported toxicity thresholds overlap with antimicrobial dose ranges, highlighting a narrow therapeutic window. The review further discusses mechanistic insights, including membrane disruption, oxidative stress induction, and ion release, as well as current limitations related to reproducibility, safety assessment, and lack of standardized dosing frameworks. Overall, while ZnO NPs demonstrate promising preclinical antimicrobial performance, their therapeutic applicability in pediatric diarrhea remains contingent upon rigorous in vivo validation and standardized safety evaluation.

Authors

Institutions

Publication Details

Journal
Food Hydrocolloids for Health
Published
2026-01-12
DOI
https://doi.org/10.1016/j.fhfh.2026.100266
Citations
1
Primary Topic
Nanoparticles: synthesis and applications
Type
article
Field-Weighted Citation Impact
16.08
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Antimicrobial properties and biomedical potential of zinc oxide nanoparticles in pediatric diarrhea: A narrative review

Ali Khorsand Zak, Hadi Khorsand Zak, Abdul Manaf Hashim
1 citations
Food Hydrocolloids for Health
Nanoparticles: synthesis and applications
16.08
article

Antimicrobial properties and biomedical potential of zinc oxide nanoparticles in pediatric diarrhea: A narrative review

Ali Khorsand Zak, Hadi Khorsand Zak, Abdul Manaf Hashim
article en
1 citations

Abstract

• This manuscript presents a narrative review of the rule of ZnO-NPs in diarrhea treatment. • We identify critical gaps in the existing literature, particularly in this topic, that require further exploration. • A novel framework is proposed to enhance understanding and guide future research directions in the field. • Our findings emphasize the importance of using ZnO-NPs in diarrhea treatments. Zinc oxide nanoparticles (ZnO NPs) have been extensively investigated for their antimicrobial activity and potential relevance to pediatric diarrhea, owing to their size-dependent reactivity and ability to generate reactive oxygen species. This review critically examines recent experimental and preclinical studies reporting the antimicrobial effects of ZnO NPs, with particle sizes typically ranging from 10 to 80 nm and effective concentrations between 5 and 200 µg/mL. In vitro studies commonly report bacterial growth inhibition rates of 60–95% against enteric pathogens such as Escherichia coli and Salmonella spp., with smaller particles and surface-modified ZnO NPs showing enhanced activity compared to bulk ZnO and soluble zinc salts. Comparative analysis indicates that ZnO NPs often achieve similar or improved antimicrobial efficacy at lower zinc doses, while also exhibiting variable cytotoxicity depending on particle size, surface chemistry, and exposure duration. However, reported toxicity thresholds overlap with antimicrobial dose ranges, highlighting a narrow therapeutic window. The review further discusses mechanistic insights, including membrane disruption, oxidative stress induction, and ion release, as well as current limitations related to reproducibility, safety assessment, and lack of standardized dosing frameworks. Overall, while ZnO NPs demonstrate promising preclinical antimicrobial performance, their therapeutic applicability in pediatric diarrhea remains contingent upon rigorous in vivo validation and standardized safety evaluation.

Food Hydrocolloids for HealthVol. 9
North Khorasan University of Medical Sciences (IR), Esfarayen University of Technology (IR), University of Technology Malaysia (MY)
Openalex Percentile: Top 3%
Nanoparticles: synthesis and applications
16.08
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.